These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6630284)

  • 1. Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy.
    Lenzhofer R; Dudczak R; Gumhold G; Graninger W; Moser K; Spitzy KH
    J Cancer Res Clin Oncol; 1983; 106(2):136-42. PubMed ID: 6630284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Doxorubicin-induced cardiomyopathy: hemodynamic studies for evaluating the limit of therapeutic risk].
    Lenzhofer R; Magometschnigg D
    Z Kardiol; 1983 May; 72(5):297-303. PubMed ID: 6880337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of cardiac function during doxorubicin therapy in metastasized breast cancer. Measuring systolic time interval].
    Lenzhofer R; Dudczak R; Dittrich C; Gumhold G; Moser K; Spitzy KH
    Dtsch Med Wochenschr; 1983 May; 108(20):771-5. PubMed ID: 6840008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity.
    McKillop JH; Bristow MR; Goris ML; Billingham ME; Bockemuehl K
    Am Heart J; 1983 Nov; 106(5 Pt 1):1048-56. PubMed ID: 6637763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiomyopathy due to adriamycin: the possibility of its prevention. Monitoring by noninvasive technics].
    Bianchi L; Bertocchi C; Felci U; Ferrario G; Giani P; Mariani L; Medolago G; Sarti E
    Minerva Med; 1989 Mar; 80(3):215-26. PubMed ID: 2717043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential equilibrium gated radionuclide angiocardiography for the detection of doxorubicin cardiotoxicity.
    Pauwels EK; Horning SJ; Goris ML
    Radiother Oncol; 1983 Aug; 1(1):83-7. PubMed ID: 6095370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized study of the role of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathy.
    Dresdale AR; Barr LH; Bonow RO; Mathisen DJ; Myers CE; Schwartz DE; d'Angelo T; Rosenberg SA
    Am J Clin Oncol; 1982 Dec; 5(6):657-63. PubMed ID: 7165010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of tests for monitoring doxorubicin-induced cardiomyopathy.
    Ganz WI; Sridhar KS; Ganz SS; Gonzalez R; Chakko S; Serafini A
    Oncology; 1996; 53(6):461-70. PubMed ID: 8960141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity.
    Steinberg JS; Wasserman AG
    Clin Ther; 1985; 7(6):660-7. PubMed ID: 3907840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast.
    Speyer JL; Green MD; Dubin N; Blum RH; Wernz JC; Roses D; Sanger J; Muggia FM
    Am J Med; 1985 Apr; 78(4):555-63. PubMed ID: 3838618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
    Morgan RJ; Doroshow JH; Venkataraman K; Chang K; Raschko J; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Margolin K; Forman S; Akman S; Coluzzi P; Ahn C; Weiss L; Gadgil U; Harrison J
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide ejection fraction in doxorubicin cardiotoxicity.
    Morgan GW; McIlveen BM; Freedman A; Murray IP
    Cancer Treat Rep; 1981; 65(7-8):629-38. PubMed ID: 7248982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas.
    Dresdale A; Bonow RO; Wesley R; Palmeri ST; Barr L; Mathison D; D'Angelo T; Rosenberg SA
    Cancer; 1983 Jul; 52(1):51-60. PubMed ID: 6850545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
    Speyer JL; Green MD; Zeleniuch-Jacquotte A; Wernz JC; Rey M; Sanger J; Kramer E; Ferrans V; Hochster H; Meyers M
    J Clin Oncol; 1992 Jan; 10(1):117-27. PubMed ID: 1727913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring of heart function in the treatment with cardiotoxic cytostatic drugs].
    Richter von Arnauld HP; Kleeberg UR; Hassel C; Mergenthaler G; Erdmann H
    Onkologie; 1984 Feb; 7 Suppl 1():55-61. PubMed ID: 6371643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.
    Hortobagyi GN; Frye D; Buzdar AU; Ewer MS; Fraschini G; Hug V; Ames F; Montague E; Carrasco CH; Mackay B
    Cancer; 1989 Jan; 63(1):37-45. PubMed ID: 2910423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment.
    Lenzhofer R; Ganzinger U; Rameis H; Moser K
    J Cancer Res Clin Oncol; 1983; 106(2):143-7. PubMed ID: 6630285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.